Free delivery over $100 Learn more

30 days return period Learn more
SKU: 0765ATC

MDA-MB-468 Human Breast Epithelial Cells

Tumor Cell Lines > Breast Cancer Cell Lines

Product Type: Human Breast Cancer Cell Lines

Species: Human

Cell Type: Epithelial Cells

Source Organ: Breast

$1,249.00
Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: MDA-MB-468

The MDA-MB-468 cell line was isolated in 1977 by R. Cailleau, et al., From a pleural effusion of a 51-year-old Black female patient with metastatic adenocarcinoma of the breast.

  • Description
    MDA-MB-468 is a human epithelial tumor cell line derived from pleural effusion of a 51-year-old Black female patient with metastatic adenocarcinoma of the breast, classified as triple-negative breast cancer (TNBC). The cell line exhibits characteristics of basal-like TNBC and has an epithelial-like morphology. The cells are small, adherent, and can present multinucleated characteristics as they approach confluence, with debris becoming noticeable. The karyotype is complex, with chromosomal aberrations commonly seen in TNBC. They highly express glucose-6-phosphate dehydrogenase (G6PD). The cell line is tumorigenic in immunodeficient mice, and while metastatic behavior is likely, it is not fully characterized. There are no specific viral properties associated with this cell line, and it serves as a model for studying triple-negative breast cancer.
  • Product Name
    MDA-MB-468
  • Product Type
    Human Breast Cancer Cell Lines
  • Species
    Human
  • Cell Type
    Epithelial
  • Source Organ
    Breast
  • Product Type
    Human Breast Cancer Cell Lines
  • Growth Conditions
    37 °C
  • Application
    MDA-MB-468 is a key model for investigating the gene expression of basal-like TNBC and identifying the signal activators and transducers in signaling pathways that regulate or suppress cell growth and survival. Unlike ER-positive and HER2-amplified cancers, TNBC exhibits stronger resistance to hormone and HER2-targeted therapies, primarily due to the absence of frequent oncogenic driver mutations. Therefore, MDA-MB-468 is crucial in breast cancer research. For instance, the of MDA-MB-468 in TNBC xenograft models has confirmed the inhibitory effect of IMMU-132, an antibody-drug conjugate targeting Trop-2, on tumor growth.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    L-15 Medium + 10% FBS
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

    • Visit our support center

      Expert help & advice

    • Check your order status

      Updates & tracking

    • Returns & exchanges

      All you need to know

    • Price-match guarantee

      Our promise to you